Flourescence detection of human malignancies using incoherent light systems

Medical Laser Application

Volumn 18, Issue 1, 2003, Pages 27-35

  Ehrhardt, André ^a,b   Stepp, Herbert ^a   Irion, Klaus Martin ^b   Stummer, Walter ^a   Zaak, Dirk ^a   Baumgartner, Reinhold ^a   Hofstetter, Alfons ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Karl Storz GmbH and Co KG   (Germany)

Author keywords

5 aminolevulinic acid; Early stage cancer; Endoscopy; Fluorescence diagnosis; Incoherent light systems

Indexed keywords

COST EFFECTIVENESS; FLUORESCENCE; NEUROSURGERY; TUMORS; UROLOGY;

MEDICAL FACULTIES;

LASER APPLICATIONS;

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

CANCER SCREENING; EARLY CANCER; EARLY DIAGNOSIS; FLUORESCENCE; HUMAN; ILLUMINATION; LASER; NEUROSURGERY; REVIEW; URINARY TRACT CANCER;

EID: 0037398959     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1078/1615-1615-00084     Document Type: Review

References (32)

1. BAUMGARTNER R, KRIEGMAIR M, HOFSTETTER A: Fluoreszenzdiagnostik des Harnblasenkarzinoms mit 5-Aminolävulinsäure - Grundlagen und Ergebnisse. Verlag EndoPress, Tuttlingen 1999
2. D'HALLEWIN MA, BEZDETNAYA L, GUILLEMIN F: Fluorescence detection of bladder cancer: a review. Eur Urol 42: 417-425 (2002)
3. D'HALLEWIN MA, KAMUHABWA AR, ROSKAMS T, DE WITTE PA, BAERT L: Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89: 760-763 (2002)
4. DIVARIS DXG, KENNEDY JC, POTTIER RH: Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 136: 891-897 (1990)
5. ENNIS SR, NOVOTNY A, XIANG J, SHAKUI P, MASADA T, STUMMER W, SMITH DE, KEEP RF: Transport of 5-aminolevulinic acid between blood and brain. Brain Res 959: 226-234 (2003)
6. FILBECK T, ROESSLER W, KNÜCHEL R, STRAUB M, KIEL HJ, WIELAND WF: Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol 13: 2 (1999)
7. FILBECK T, PICHLMEIER U, KNUECHEL R, WIELAND WF, ROESSLER W: Clinically relevant improvement of recurrencefree survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 168: 67-71 (2002)
8. FILBECK T, PICHLMEIER U, KNUECHEL R, WIELAND WF, ROESSLER W: Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma. Urology 60: 1025-1028 (2002)
9. FRIMBERGER D, ZAAK D, HOFSTETTER A: Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder. Seminars in Urologic Oncology 18: 264-272 (2000)
10. HÄUSSINGER K, STANZEL F, HUBER R. M, PICHLER J, STEPP H: Autofluorescence detection of bronchial tumors with the D-light/AF. Diagnostic and Therapeutic Endoscopy 5: 105-112 (1999)
11. HÄUSSINGER K, PICHLER J, STANZEL F, MARKUS A, STEPP H, MORRESI-HAUFF A, BAUMGARTNER R: Autofluorescence bronchoscopy: The D-light system. Prog Respir Res Basel Karger 30: 243-252 (2000)
12. HARTMANN A, MOSER K, KRIEGMAIR M, HOFSTETTER A, HOFSTAEDTER F, KNUECHEL R: Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 154: 721-727 (1999)
13. HOFSTETTER A, ZAAK D: Diagnosis and treatment of nonmetastasized superficial bladder cancer must be reconsidered. Lasermed 15: 206-211 (2000)
14. JICHLINSKI P, FORRER M, MIZERET J, GLANZMANN T, BRAICOTTE D, WAGNIERES G, ZIMMER G, GUILLOU L, SCHMIDLIN F, GRABER P, VAN DEN BERGH H, LESINGER HJ: Clinical evaluation for detecting superficial transition cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: Preliminary results. Lasers in Surgery and Medicine 20: 402-408 (1997)
15. KOENIG F, KNITTEL J, STEPP H: Diagnosing cancer in vivo. Science. 2292: 1401-1403 (2001)
16. KRIEG RC, MESSMANN H, RAUCH J, SEEGER S, KNUECHEL R: Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells. Photochem Photobiol 76: 518-525 (2002)
17. KRIEGMAIR M, BAUMGARTNER R, KNÜCHEL R, EHSAN A, STEINBACH P, LUMPER W, HOFSTÄDTER F, HOFSTETTER A: Photodynamische Diagnose urothelialer Neoplasien nach intravesikaler Instillation von 5-Aminolävulinsäure. Urologe 33:270-275 (1994)
18. KRIEGMAIR M, ZAAK D, STEPP H, STEPP HG, BAUMGARTNER R, HOFSTETTER A: Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur Urol 36: 386-392 (1999)
19. KRIEGMAIR M, ZAAK D, KNUECHEL R, BAUMGARTNER R, HOFSTETTER A: 5-aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors. Urol Int 63: 27-31 (1999)
20. KRIEGMAIR M, ZAAK D, KNUECHEL R, BAUMGARTNER R, HOFSTETTER A: Photodynamic cystoscopy for detection of bladder tumors. Semin Laparosc Surg 6: 100-103 (1999)
21. LANGE N, JICHLINSKI P, ZELLWEGER M, FORRER M, MARTI A, GUILLOU L, KUCERA P, WAGNIERES G, VAN DEN BERGH H: Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80: 185-193 (1999)
22. LEONHARD M: New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diagnostic and Therapeutic Endoscopy 5: 71-75 (1999)
23. th world congress for bronchology. BEAMIS JF, SHAPSHAY SM (Eds), Monduzzi Editore S.p.A.: 121-124 (2002)
24. RIEDL RC, DANILTCHENKO D, KOENIG F, SIMAK R, LOENING AS, PFLUEGER H: Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. The journal of urology 165: 1121-1123 (2001)
25. STEPP H, BAUMGARTNER R, BEYER W, KNÜCHEL R, KÖRNER TO, RICK K, KRIEGMAIR M, STEINBACH P, STEPP H. G, HOFSTETTER A: Fluorescence imaging and spectroscopy of ALAinduced protoporphyrin IX preferentially accumulatedd in tumour tissue. In: Optical Biopsies. CUBEDDU R, MORDON SR, SVANBERG K (Eds). Proc SPIE 2627: 13-24 (1995)
26. STUMMER W, STOCKER S, WAGNER S, STEPP H, FRITSCH C, GOETZ C, GOETZ AE, KIEFMANN R, REULEN HJ: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42: 518-525 (1998)
27. STUMMER W, STEPP H, MÖLLER G, EHRHARDT A, LEONHARD M, REULEN HJ: Technical principles for Protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir 140: 995-1000 (1998)
28. STUMMER W, NOVOTNY A, STEPP H, GOETZ C, BISE K, REULEN HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acidinduced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93: 1003-1013 (2000)
29. WAGNER S: Fluoreszenzquantifizierung beim Harnblasenkarzinom nach Instillation von 5-Aminolävulinsäure. Dissertation an der Medizinischen zMünchen 2000
30. ZAAK D, WAGNER S, STEPP H, BAUMGARTNER R, KRIEGMAIR M, HOFSTETTER AG, KNUECHEL R: Fluoreszenzquantifizierung bei der 5-Aminolävulinsäure induzierten Fluoreszenzendoskopie des oberflächlichen Harnkarzinoms. Akt Urol 29: 39 (1998)
31. ZAAK D, HOFSTETTER AG, BAUMGARTNER R, STEPP H, STEPP HG, WAGNER S, KNUECHEL R, SCHMELLER N, STIEGELMAYR A, FRIMBERGER D, KRIEGMAIR M: Die 5-Aminolävulinsäure-induzierte Fluoreszenzendoskopie des oberflächlichen Harnblasenkarzinoms. Urologe B (39): 113-120 (1999)
32. ZAAK D, HUNGERHUBER E, SCHNEEDE P, STEPP H, FRIMBERGER D, CORVIN S, SCHMELLER N, KRIEGMAIR M, HOFSTETTER A, KNUECHEL R: Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer. 95: 1234-1238 (2002)